|
 |
ValsartanThis page contains recent news articles, when available, and an overview of Valsartan but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Valsartan (when available) Valsartan, a specific angiotensin II antagonist, is used alone or with other antihypertensive agents to treat hypertension. Unlike the angiotensin receptor antagonist losartan, Valsartan does not have an active metabolite or possess uricosuric effects. For the treatment of hypertension Mechanism Of Action: Valsartan competes with angiotensin II for binding at the AT1 receptor subtype. As angiotensin II is a vasoconstrictor which also stimulates the synthesis and release of aldosterone, blockage of its effects results in a decreases in systemic vascular resistance. News Articles on Valsartan James Ray's Sedona sweat lodge stash: lessons in polypharmacy - 06 Jan 2010 There were also some other drugs found in Ray's room at the lodge that included that also included Diovan (valsartan), an antihypertensive of that ... ScienceBlogs (blog) VALTURNA 150mg/160mg - Dec 11, 2009 Valturna combines aliskiren, a direct renin inhibitor, and valsartan, an angiotensin II receptor blocker (ARB). Renin is secreted by the kidneys in response ... Monthly Prescribing Reference Novartis Snags Heart Drug with $620M Corthera Bid - Dec 23, 2009 Basel, Switzerland-based Novartis, which currently markets the heart failure drug Diovan (valsartan), is acquiring all of privately held Corthera's ... BioWorld Online EU Panel Backs DuoCover From Bristol-Myers Squibb Pharma - Dec 18, 2009 ...-The CHMP recommended a line extension for Diovan (valsartan), from Novartis Pharma AG, to add an oral solution, a pharmaceutical formulation suitable for ... Wall Street Journal Novartis to acquire Corthera Inc., gaining worldwide rights to Phase III ... - Dec 28, 2009 ..."This transaction highlights relaxin's potential as an important treatment option for patients suffering from acute heart failure" * Diovan (valsartan) - an ... PR-CANADA.net (press release) Pharmaceutical industry financial performance - Dec 11, 2009 Lilly), montelukast (Singulair; Merck), clopidogrel (Plavix; Bristol–Myers Squibb/Sanofi–Aventis), valsartan (Diovan; Novartis) and topiramate (Topamax; ... Nature.com (subscription) Novartis erwirbt Phase-III-Produktkandidat bei Herzversagen für 120 Mio USD (AF) - Dec 22, 2009 Dieses besteht derzeit ua aus dem Blutdrucksenker und "Blockbuster" Diovan (Valsartan), dem Nachfolgeprodukt Tekturna/Rasilez (Aliskiren) in Phase III, ... Handelszeitung Online Novartis/EMEA-Ausschuss empfiehlt Impfstoff Menveo zur Zulassung - Dec 18, 2009 Gleichzeitig empfiehlt der Ausschuss eine Erweiterung für das Novartis-Produkt Diovan (Valsartan). Neu soll Diovan um eine orale Lösung ergänzt werden, ... Handelszeitung Online 진료패턴ì?„ 바꿀 ìµœì‹ ìž„ìƒ?연구Ⅲ - Dec 27, 2009 ...좌심실 기능ì?´ 떨어진 post-MI 환ìž?를 대ìƒ?으로 í•œ 'VALIANT'연구ì—?ì„œ 발살탄(valsartan) 320mgêµ°ê³¼ ìº¡í† í”„ë¦´ 150mgêµ°ì?˜ 사ë§?ë¥ ì?€ ì°¨ì?´ê°€ 없었다. ... KMA Times CBG: positief advies voor DuoCover, negatief advies voor Cerepro - Dec 24, 2009 De CHMP heeft een drankje van Diovan (valsartan) goedgekeurd om dit geneesmiddel beter geschikt te maken voor gebruik bij kinderen. ... Medical facts Valsartan Better Than Continuous Positive Airway Pressure Therapy in ... - Nov 6, 2009 SAN DIEGO -- November 6, 2009 -- Valsartan produced a 3-fold higher decrease in blood pressure than did continuous positive airway ... DG News Novartis high blood pressure drug approved in EU - Oct 23, 2009 The drug combines in a once-daily single pill the efficacy of three widely prescribed blood pressure medications: the angiotensin receptor blocker valsartan ... Therapeutics Daily (press release) (registration) Predictors of Sudden Cardiac Death Change With Time After Myocardial ... - Nov 12, 2009 Methods: This was a post-hoc analysis of a randomized clinical trial of valsartan versus captopril in 11256 patients (mean age 65 years) with an acute MI ... Cardiosource Novartis Gets Approval In European Union For Exforge HCT, New 3-in-1 Treatment ... - Oct 24, 2009 ...pressure medications, namely the angiotensin receptor blocker valsartan, the calcium channel blocker amlodipine, and the diuretic hydrochlorothiazide. ... RTT News Novartis wins EU approval for blood pressure drug - Oct 27, 2009 ...of three widely prescribed blood pressure medications: the angiotensin receptor blocker valsartan, the calcium channel blocker amlodipine, and the HCT. ... Therapeutics Daily (press release) (registration) Daily News: New Combination Pill for Hypertension - Nov 1, 2009 The US Food and Drug Administration recently approved Valturna, an antihypertensive combination of aliskiren (a direct renin inhibitor) and valsartan (an ... Nurse.com Solid quarter for Novartis as firm waits for swine flu windfall - Oct 22, 2009 Novartis' biggest-seller was the blood pressure lowerer Diovan (valsartan), though sales increased just 1% to $1.46 billion, while sales of Glivec/Gleevec ... Pharma Times FDA Approves New Use for Micardis(R) in Cardiovascular Risk Reduction and ... - Oct 19, 2009 Wogen J, Kreilick C, Livornese R, Yokoyama K, Frech F. Patient adherence with amlodipine, lisinopril or valsartan therapy in a usual-care setting. JMCP. ... Reuters PBS listings in effect - Nov 2, 2009 ...which allows patients to have a combination of Ezetimibe with simvastatin in the one product; Co-Diovan (valsartan with hydrochlorothiazide), ... Pharmacy News PRESS RELEASE: Novartis Delivers Strong New -4- - Oct 21, 2009 Exforge (USD 475 million +81% lc), a single pill with the angiotensin receptor blocker Diovan (valsartan) and the calcium channel blocker amlodipine, ... Capital.gr (press release) GSK, 'í”„ë¦¬í† í”ŒëŸ¬ìŠ¤'출시 - Nov 12, 2009 GSK는 í”„ë¦¬í† í”ŒëŸ¬ìŠ¤ 80/25는 ìž„ìƒ?연구결과 Valsartan/HCTZ 160mg/25mg보다 혈압강하효과가 ê°•ë ¥í–ˆë‹¤ê³ ë°?혔다. 105ê°œ ìž„ìƒ?시험센터ì—?ì„œ 진행ë?œ 대규모 ìž„ìƒ?연구ì—? ... 메디포뉴스 EXFORGEì?˜ 효능 효과 - Nov 2, 2009 Valsartanì?€ ì‹¬ë¶€ì „í™˜ìž?를 대ìƒ?으로 í•œ Val-HeFT시험ì—?ì„œ ì?´ëŸ¬í•œ ìœ ì?µí•œ 효과가 ìž…ì¦?ë?˜ì—ˆëŠ”ë?° 기존 치료만 ìœ ì§€í•œ 위약 êµ°ì—? 비해서 valsartanì?„ 투여한 êµ°ì—?서는 13% ... 코리아헬스로그 Erste fixe Dreifachkombination zugelassen - Nov 3, 2009 Sie enthält die drei Antihypertensiva Amlodipin, Valsartan und Hydrochlorothiazid, die seit langem eingesetzt werden. Zugelassen ist das Präparat bei ... DAZ.online Novartis: l'UE homologue Exforge HCT pour traiter l'hypertension - Oct 22, 2009 Il s'agit d'un médicament combinant le Diovan (Valsartan), l'Amlodipine et l'Hydrochlorothiazid, ce qui permet une prise unique en un seul comprimé, ... Romandie.com Résumé du jour - Economie - Vendredi 23 octobre 2009 - Oct 23, 2009 Ce médicament du groupe pharmaceutique bâlois représente une combinaison du Diovan (Valsartan), du l'Amlodipine et de l'Hydrochlorothiazid. ... Romandie.com ìœ ëŸ½ìœ„ì›?회, 노바티스 '엑스í?¬ì§€ HCT' 허가 - Oct 26, 2009 ...김윤ì˜? 기ìž? 노바티스ì?˜ ê³ í˜ˆì•• ë³µí•©ì œ '엑스í?¬ì§€ HCT'(valsartan-amlodipine-hydrochlorothiazide)ì—? 대해 ìœ ëŸ½ 위ì›?회가 ì‹œíŒ?ì?„ 허가했다. EUì—?서는 엑스í?¬ì§€ HCT를 ... 메디포뉴스 Signal aus dem Bauch - Oct 29, 2009 20 Probanden schluckten das Mittel Valsartan. Dies war so präpariert, dass bei der säureabhängigen Zersetzung der Pille im Magen ein elektrisches Signal ... sueddeutsche.de Novartis erhält EU-Zulassung für Bluthochdrucksenker-Kombi Exforge HCT - Oct 22, 2009 Beim Medikament handelt es sich um die Kombination von Diovan (Valsartan), Amlodipin und Hydrochlorothiazid in einer einzigen Tablette, ... Handelszeitung Online د. عبد الرØيم خاسكية يتØدث عن ارتÙ?اع ضغط الدم - Nov 2, 2009 على سبيل المثال هناك دواء جديد يسمى Exforge يتكون من دوائين ناجØين ومعروÙ?ين هما amlodipine+valsartan .لقد اظهر هذا الدواء نجاØا بعلاج الضغط مع اضرار جانبية ... بانوراما GSK, í”„ë¦¬í† í”ŒëŸ¬ìŠ¤ 80/25mg 출시 - Oct 21, 2009 ...ê¹€ì?€ì•„ 기ìž? GSK는 í•ê³ 혈압 ë³µí•©ì œ 'í”„ë¦¬í† í”ŒëŸ¬ìŠ¤'(텔미살탄+하ì?´ë“œë¡œí?´ë¡œë¡œì¹˜ì•„짓)ì?˜ 새로운 용량ì?„ ì¶œì‹œí–ˆë‹¤ê³ 21ì?¼ ë°?혔다. ì?´ë²ˆì—? ì„ ë³´ì?¸ ì œí’ˆì?€ 기존 'í”„ë¦¬í† ... KMA Times DJ HUGIN NEWS/Novartis verzeichnet in den ersten -6- - Oct 21, 2009 Klinischen Daten zufolge senkt dieses Medikament den Blutdruck signifikant stärker als Valsartan oder Aliskiren allein, was die Zulassung unterstützte. ... unternehmer.de India's Ranbaxy gets tentative FDA approval for Valsartan tablets - Oct 29, 2007 BANGALORE (Thomson Financial) - India's Ranbaxy Laboratories Ltd said it has received tentative approval from the US Food and Drug Administration to ... Forbes Blood Pressure Drug Might Work Against Alzheimer's - Oct 25, 2007 The potential value of valsartan, marketed as Diovan, emerged from a screening ... Specifically, valsartan interfered with the formation of clumps of the ... Washington Post … Goal: Influence of Dose of Valsartan Monotherapy and Valsartan and... - Nov 14, 2006 Background: Our objective was to assess time to achieve blood-pressure (BP) goal with incremental doses of valsartan alone, and together with ... Nature.com Effect of valsartan addition to amlodipine on ankle oedema and … - Jul 28, 2006 Correspondence: Dr R Fogari, Dipartimento di Medicina Interna, Clinica Medica II, Policlinico S Matteo, Piazza Golgi 19 27100 Pavia, Italy. ... Nature.com Can valsartan reduce the occurrence of atrial fibrillation in heart... - May 30, 2005 Maggioni AP et al. (2005) Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure ... Nature.com … design of the KYOTO HEART study: effects of valsartan on morbidity... - Sep 18, 2008 16 The JIKEI Heart study demonstrated a preventive action of valsartan, ... The KHS was also designed to examine whether valsartan added to conventional ... Nature.com Is valsartan renoprotective in patients with IgA nephropathy? - May 21, 2006 Li PK et al. (2006) Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study. ... Nature.com The angiotensin II receptor antagonist valsartan inhibits endothelin... - Aug 2, 2005 ...* This study was supported in part by the Deutsche Forschungsgemeinschaft (DFG, MI 1141/1-2/WE 1772/3-3) and the Oertel Foundation. ... Nature.com Comparison between valsartan and valsartan plus cilnidipine in type... - May 17, 2006 Correspondence: K Katayama, First Department of Internal Medicine, Mie University, Mie, 21-153 Noda, Tsu, Mie 514-0826, Japan. E-mail: a3huufbj@ztv.ne.jp ... Nature.com Novartis' blood pressure drug Exforge receives final clearance by FDA - Jun 21, 2007 Exforge combines in one tablet the two most commonly prescribed hypertension medicines in their categories -- Diovan (valsartan) and Norvasc (amlodipine ... Forbes Valsartan Has Blood Pressure Lowering Effect Across Cardiovascular … - Oct 30, 2008 By Marvin Ross. TORONTO -- October 30, 2008 -- Significant reductions in blood pressure (BP) are observed across the cardiovascular (CV) continuum after 3 ... DG News … of Intensive Blood Pressure Control With Valsartan on Urinary... - Nov 21, 2005 Correspondence: Dr. Raymond O. Estacio, Dr. Raymond O. Estacio, University of Colorado at Denver, Health Sciences Center, 789 Sherman Street, Suite 200, ... Nature.com Novartis files for EU approval for Exforge blood pressure tablet - Mar 3, 2006 Exforge, a combination of the calcium channel blocker amlodipine and the angiotensin receptor blocker valsartan, has been shown in clinical trials involving ... Forbes Novel therapy in the management of hypertension: Preliminary … - Oct 24, 2005 In spontaneously hypertensive rats, aliskiren 30 mg/kg/d yielded modest BP reductions; when administered in combination with benazepril or valsartan, ... Nature.com Novartis says Exforge 'successful' in trials vs single medicines - May 21, 2007 Exforge is a single-tablet combination of two of the world's most commonly prescribed high blood pressure medicines, angiotensin receptor blocker valsartan ... Forbes Valsartan Reduces Chance of Diabetes in High-Risk Hypertensive … - May 19, 2005 By Ed Susman. SAN FRANCISCO, CA -- May 19, 2005 -- A new analysis of a major clinical trial shows that hypertensive patients treated with the angiotensin ... DG News Valsartan Plus Diuretic Has More Favourable Metabolic Effects Than … - Jun 23, 2008 By Betty S. Riggs. BERLIN -- June 23, 2008 -- In obese hypertensive patients, addition of valsartan to hydrochlorothiazide (HCTZ) was associated with ... DG News Aliskiren and Valsartan Work in Concert to Get Blood Pressure Under … - Mar 28, 2007 By Ed Susman. NEW ORLEANS, LA -- March 28, 2007 -- Researchers said that hard-to-control hypertensive patients did when they took a combination of the ... DG News Angiotensin receptor blockade protects people who have a wide range... - Sep 5, 2006 Patients were assigned either treatment with the angiotensin receptor blocker (ARB) valsartan or a non-ARB therapy, taken in addition to their current ... European Society of Cardiology Diovan(R) receives EU approval for the treatment of heart attack... - May 9, 2005 Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. ... Medical News Today - Medical News Today (press release) … eyes new use for Diovan.(Focus)(Novartis AG's valsartan is... - Jan 21, 2008 HANOVER, NJ -- Diovan (valsartan), an angiotensin receptor blocker, or ARB, has been approved after a priority review by the Food and Drug Administration ... Free with registration - Chain Drug Review - AccessMyLibrary.com Valsartan, Hydrochlorothiazide Combo Works Better Than Valsartan … - May 24, 2007 By Jill Stein. CHICAGO, IL -- May 24, 2007 -- Initial therapy with combination valsartan/hydrochlorothiazide (HCTZ) provides quicker and better blood ... DG News Amlodipine Plus Valsartan a Reasonable Choice for Stage 2 … - May 19, 2006 By Jill Stein. NEW YORK, NY -- May 19, 2006 -- A combination of amlodipine plus valsartan is a highly effective and well tolerated treatment for patients ... DG News Valsartan More Effective Than Amlodipine in Patients With Stage 2 … - Jun 20, 2008 By Betty S. Riggs. BERLIN -- June 20, 2008 -- Patients with stage 2 hypertension achieve greater reductions in 24-hour blood pressure with a fixed-dose ... DG News Early intervention can halt heart damage - Aug 28, 2007 During the next six months, both groups took Valsartan. The study participants who took the drug for the first six months significantly reduced their ... United Press International Valsartan (Systemic). - Oct 27, 2005 Valsartan ( val-SAR-tan) belongs to the class of medicines called angiotensin II inhibitors. It is used to treat high blood pressure (hypertension). ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Aliskiren/Valsartan Combo Reduces Blood Pressure Better Than Either … - Sep 8, 2008 By Jill Stein. ROME -- September 8, 2008 -- A combination of the direct-renin-inhibitor aliskiren and the angiotensin-receptor blocker valsartan reduces ... DG News Brand Names/Synonyms: Valsartan is also known by the following brand names and/or synonymsDiovan; Diovan Hct; Valsarran; Valsartan; Valsartan [Usan:Inn] Drug Category: Valsartan is categorized under the following by the FDA: Antihypertensive Agents; Angiotensin II Receptor Antagonists; ATC:C09CA03 Dosage Forms: TABLET Absorption: Not Available Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-butanoicacid |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |